HF Advisory Group LLC Increases Stake in Cardinal Health, Inc. $CAH

HF Advisory Group LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 97.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 10,227 shares of the company’s stock after acquiring an additional 5,049 shares during the period. HF Advisory Group LLC’s holdings in Cardinal Health were worth $2,102,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CAH. HMS Capital Management LLC bought a new stake in Cardinal Health in the fourth quarter worth about $224,000. Five Oceans Advisors bought a new position in shares of Cardinal Health during the fourth quarter valued at approximately $215,000. Retireful LLC purchased a new stake in shares of Cardinal Health in the fourth quarter worth approximately $272,000. Frank Rimerman Advisors LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth approximately $289,000. Finally, Nilsine Partners LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth approximately $219,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.4%

CAH opened at $212.11 on Thursday. The stock’s fifty day moving average is $217.37 and its two-hundred day moving average is $197.66. The company has a market capitalization of $49.91 billion, a P/E ratio of 30.52, a PEG ratio of 1.36 and a beta of 0.64. Cardinal Health, Inc. has a 52 week low of $120.72 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.32. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The business had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. During the same period in the prior year, the business earned $1.93 EPS. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s dividend payout ratio is presently 29.35%.

Wall Street Analysts Forecast Growth

CAH has been the topic of several research analyst reports. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Argus lifted their target price on Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, January 21st. UBS Group set a $260.00 price target on shares of Cardinal Health and gave the stock a “buy” rating in a report on Friday, February 6th. Finally, Wells Fargo & Company raised their price target on shares of Cardinal Health from $237.00 to $256.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $245.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.